ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
Eur. j. anaesthesiol; 40 (12), 2023
Publication year: 2023
In recent years, there has been increasing focus on the use of cardiac biomarkers in patients undergoing noncardiac surgery.
The aim of this focused guideline was to provide updated guidance regarding the pre-, post- and combined pre-and postoperative use of cardiac troponin and B-type natriuretic peptides in adult patients undergoing noncardiac surgery.
The guidelines were prepared using Grading of Recommendations Assessment Development and Evaluation (GRADE) methodology. This included the definition of critical outcomes, a systematic literature search, appraisal of certainty of evidence, evaluation of biomarker measurement in terms of the balance of desirable and undesirable effects including clinical outcomes, resource use, health inequality, stakeholder acceptance, and implementation.